Pharming Group (PHAR)
7.53
-0.23
(-2.96%)
USD |
NASDAQ |
Nov 22, 16:00
7.48
-0.05
(-0.66%)
After-Hours: 20:00
Pharming Group EV to EBITDA
EV to EBITDA Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EV to EBITDA Data
| Date | Value |
|---|---|
| November 22, 2024 | -- |
| November 21, 2024 | -- |
| November 20, 2024 | -- |
| November 19, 2024 | -- |
| November 18, 2024 | -- |
| November 15, 2024 | -- |
| November 14, 2024 | -- |
| November 13, 2024 | -- |
| November 12, 2024 | -- |
| November 11, 2024 | -- |
| November 08, 2024 | -- |
| November 07, 2024 | -- |
| November 06, 2024 | -- |
| November 05, 2024 | -- |
| November 04, 2024 | -- |
| November 01, 2024 | -- |
| October 31, 2024 | -- |
| October 30, 2024 | -- |
| October 29, 2024 | -- |
| October 28, 2024 | -- |
| October 25, 2024 | -- |
| October 24, 2024 | -- |
| October 23, 2024 | -- |
| October 22, 2024 | -- |
| October 21, 2024 | -- |
| Date | Value |
|---|---|
| October 18, 2024 | -- |
| October 17, 2024 | -- |
| October 16, 2024 | -- |
| October 15, 2024 | -- |
| October 14, 2024 | -- |
| October 11, 2024 | -- |
| October 10, 2024 | -- |
| October 09, 2024 | -- |
| October 08, 2024 | -- |
| October 07, 2024 | -- |
| October 04, 2024 | -- |
| October 03, 2024 | -- |
| October 02, 2024 | -- |
| October 01, 2024 | -- |
| September 30, 2024 | -- |
| September 27, 2024 | -- |
| September 26, 2024 | -- |
| September 25, 2024 | -- |
| September 24, 2024 | -- |
| September 23, 2024 | -- |
| September 20, 2024 | -- |
| September 19, 2024 | -- |
| September 18, 2024 | -- |
| September 17, 2024 | -- |
| September 16, 2024 | -- |
EV to EBITDA Definition
The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.
EV to EBITDA Range, Past 5 Years
EV to EBITDA Benchmarks
| uniQure NV | -- |
| ProQR Therapeutics NV | -- |
| Merus NV | -- |
| argenx SE | -- |
| Pharvaris NV | -- |